SyntheticGestalt, a company aiming to realise drug discovery by artificial intelligence, today announced the update of its Corporate Identity (CI).
These changes come as the company expands its capabilities, preparing for further growth to implement drug discovery by artificial intelligence to society.
“It has been more than three years since we founded this company with an ambitious mission. We have now redesigned our CI to better embody the values and mission of the company,” said Koki Shimada, CEO of SyntheticGestalt. “We believe in the process of self-organisation from diverse values and perspectives to create new ideas. In our new logo, we express this process by layering a variety of patterns and colours to create a unique pattern. The new ideas that emerge from the self-organised processes in our company are not random, but mission-driven and will-driven. To express the presence of this will, we have chosen to apply a square shape, to represent artificiality.”
The new CI was produced through a lithograph printing process, committing layers of pixel-like ink dots of various colors on paper that together express SyntheticGestalt’s members and the interactions between them. The emergence of the superstructure that is our CI reflects the company’s vision to “Develop an autonomous system to make valuable discoveries en masse.”
The newly-updated website, reflecting our renewed Key Visuals, showcases the company’s values and its strengths, including its employees. SyntheticGestalt invites all to explore its new site.